Vascular repair by endothelial progenitor cells in an experimental model of metabolic syndrome

Handbook on Metabolic Syndrome: Classification, Risk Factors and Health Impact

Volumn , Issue , 2012, Pages 287-303

  Renna, Nicolás F ^a,b,c   Lembo, Carina ^a,b   Lama, María C ^b   González, Elsa S ^a,b   Miatello, Roberto M ^a,b  

^a UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Endothelial progenitor cells; Fructose fed rats; Hypertension; Metabolic syndrome; Oxidative stress; Vascular remodelling

Indexed keywords

EID: 84873399953     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (36)

1. Kaplan N. The deadly quartet hyperbody obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989.149.1514-1520.
2. Reaven G, Laws A. Insulin resistance, compensatory hyperinsulinemia and coronary heart disease. Diabetologia 1994. 37.948-952.
3. de Champlain J, Wu R, Girouard H, Karas M, EL Midaoui A, Laplante MA, Wu L. Oxidative stress in hypertension. Clin Exp Hypertens 2004. 26.593-601.
4. Hwang I, Ho H, Hoffman B, Reaven G. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987.10.512-516.
5. Miatello R, Risler N, Castro C, Gonzalez S, Rüttler M, Cruzado M. Aortic smooth muscle cell proliferation and endothelial nitric oxide synthase activity in fructose-fed rats. Am J Hypertens 2001.14.1135-1141.
6. Bell R, Ryan E, Finegood D. Consequences of high dietary fructose in the islettransplanted rat with suboptimal beta-cell mass. Am J Physiol 1996.270.E292-298.
7. Miatello R, Cruzado M, Risler N. Mechanisms of cardiovascular changes in an experimental model of syndrome X and pharmacological intervention on the reninangiotensin-system. Curr Vasc Pharmacol. 2004.2(4).271-277.
8. Renna NF, Vazquez MA, Lama MC, González ES, Miatello RM. Effect of chronic aspirin administration on an experimental model of metabolic syndrome. Clin Exp Pharmacol Physiol. 2009 Feb.36(2).162-8
9. Intengan HD and Schiffrin EL. Vascular Remodeling in hypertension. roles of apoptosis, inflammation and fibrosis. Hypertension. 2001. 38[part 2]. 581-587 .
10. Fortuño A, San Jose G, Moreno MU, Diez J, Zalba G. Oxidative Stress and Vascular Remodelling. Exp Physiol 2005. 4. 427-462
11. Renna N, Risler N, Cruzado M, Gonzalez S, Lama M, Miatello R. Effect of Nebivolol on Cardiovascular Changes Associated to a Model of Insulin-Resistance. Cell Mol Biol 2005. 51(6).531-537.
12. Miatello R, Vázquez M, Renna N, Cruzado M, Ponce Zumino A, Risler N. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructosefed rats. Am J Hypertens 2005.18.864-870.
13. Leri A, Anversa P, Frishman W. Cardiovascular Regeneration and Stem Cell Therapy. Blackwell-Futura. ISBN. 978-1-4051-4842-9
14. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003.348. 593-600.
15. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997. 275. 964-967
16. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med. 2003. 9. 1370-1376
17. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002. 106. 2781-2786.
18. Hristov M, Erl W, Weber P. Endothelial Progenitor Cells. Mobilization, Differentiation, and Homing. Arterioscler Thromb Vasc Biol 2003.23.1185-1189.
19. Metharom P. Caplice NM. Vascular Disease. A new Progenitor Biology. Curr Vasc Pharmacol. 2007 Jan.5(1).61-8. Review
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment. insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985. 28.412-419.
21. Lapenna D, Ciofani G, Pierdomenico S, Giamberardino M, Cuccurullo G. Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radical Biol Med 2001. 31(3).331-335.
22. Cruzado M, Risler N, Miatello R, Yao G, Schiffrin E, Touyz R. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension. effect of angiotensin II and role of insulin-like growth factor-1 receptor transactivation. Am J Hypertens 2005.18.81-87.
23. Renna N, Risler N, Cruzado M, Gonzalez S, Lama M, Miatello R. Effect of Nebivolol on Cardiovascular Changes Associated to a Model of Insulin-Resistance. Cell Mol Biol 2005. 51(6).531-537.
24. Mulvany MJ. Remodelling of resistance vessels in essential hypertension. In. Hypertension. Ed. Oparill S, Weber HA, Saunders, Philadelphia, 2000, 125-134.
25. Mulvany MJ. Resistance vessel growth and remodelling. cause or consequence in cardiovascular disease. J Hum Hypertens, 1995, 9, 479-485.
26. McGrath JC, Deighan C, Briones A, Shafaroudi MM, McBride M, Adler J, Arribas S, Vila E, Daly E. New aspects of vascular remodelling. the involvement of all vascular cell types. Exp Physiol 2005.90.469-475.
27. Folkow B. "Structural factor" in primary and secondary hypertension. Hypertension 1990.16.89-101.
28. Lever AF, Harrap SB. Essential hypertension. a disorder of growth with origins in childhood? J Hypertens 1992.10.101-20.
29. Miatello R, Risler N, Gonzalez S, Castro C, Rüttler M, Cruzado M. Effects of enalapril on the vascular wall in an experimental model of syndrome X. Am J Hypertens 2002.15.872-878.
30. Miatello R, Risler N, Castro C, Cruzado M, González S, Ponce Zumino A. Chronic administration of losartan reverses cardiovascular changes in hypertensive fructose-fed rats. Cell Mol Biol 2003.49.945-952.
31. Ross R. Atherosclerosis. an inflammatory disease. N Engl J Med. 1999. 340.115-126.
32. Urbich C, Dimmeler S. Endothelial Progenitor Cells. Characterization and Role in Vascular Biology. Circ. Res. 2004.95.343-353.
33. Ii M, Losordo D. Transplant Graft Vasculopathy. A Dark Side of Bone Marrow Stem Cells? Circulation 2003.108.3056-3058.
34. Szmitko P, Fedak P, Weisel R, Stewart D, Kutryk M, Verma S. Endothelial Progenitor Cells. New Hope for a Broken Heart. Circulation 2003.107.3093-3100.
35. Hill J, Zalos G, Halcox J, Schenke W, Waclawiw M, Quyyumi A, Finkel T, Circulating Endothelial Progenitor Cells,Vascular Function, and Cardiovascular Risk. N Engl J Med 2003.348.593-600.
36. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, Menegolo M, Vigili de Kreutzenberg S, Tiengo A, Agostini C, Avogaro A. Circulating Endothelial Progenitor Cells Are Reduced in Peripheral Vascular Complications of Type 2 Diabetes Mellitus. J Am Coll Cardiol 2005.45.1449-57.